홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RVPH
#4846
Reviva Pharmaceuticals Holdings, Inc. Common Stock
0.8
6
USD
-1.15%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-1.15%
월간 변동
-65.04%
6달 변화
+34.38%
년간 변동율
+10.26%
이전 종가
0.8
7
Open
0.8
6
Bid
Ask
Low
0.8
6
High
0.8
6
양
3
마켓
주식
헬스케어
RVPH
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
461.59 K
756.66 K
1.02 M
1.4 M
2.34 M
12.81 M
—
Valuation ratios
Enterprise value
71.97 M
14.05 M
62.47 M
124.88 M
71.12 M
57.04 M
141.11 M
Price to earnings ratio
—
—
-3.18
-3.22
-2.01
-1.02
-3.47
Price to sales ratio
—
—
-396.93
-528.26
83.6
227.43
925.82
Price to cash flow ratio
—
—
-4.08
-4.46
-1.79
-0.82
-3.11
Price to book ratio
—
—
6.27
22.1
73.84
2.34
-27.12
EBITDA 비율에 대한 기업 가치
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.43
-0.27
-1.29
-1.66
-1.93
-1.25
-1.92
Return on equity %
-0.51
-0.3
-1.98
-6.87
-36.82
-2.3
13.36
Return on invested capital %
-32
-25.89
-3 005.85
-2 076.88
-1 214.46
-1 369.6
-1 432.27
Gross margin %
—
—
100
100
100
100
400
Operating margin %
—
—
12.48 K
16.51 K
-4 291.66
-22.69 K
-58.78 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
12.5 K
16.41 K
-4 169.03
-22.32 K
-58.07 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.69
12.66
3.07
1.36
1.01
2.08
4.9
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
-0.01
-0.01
0.04
0.01
0.01
Solvency ratios
Debt to assets ratio
0
—
—
—
—
—
—
Debt to equity ratio
0
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-19.43
-23.8
-20.24
-6.78
-8.52
EBIT per share
—
—
-25.11
-33.4
-18.15
-5.54
-7.18
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
18.98
19.64
8.13
3.98
13.94
Net current asset value per share
—
—
18.98
19.64
8.86
4.16
14.79
Tangible book value per share
—
—
12.62
4.81
0.49
2.38
1.62
Working capital per share
—
—
12.79
5.2
0.05
2.16
0.53
Book value per share
—
—
12.62
4.81
0.49
2.38
1.62
뉴스
Does Cobenfy Have the Potential to Become a Top Drug for BMY?
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.44%
D. Boral Capital, Reviva Pharmaceuticals 투자의견을 ’보유’로 하향 조정
D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold
Reviva Pharmaceuticals, 3월 9일 20대 1 주식 병합 실시
Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9
브릴라록사진, 음성 바이오마커 연구에서 정신분열증 효능 입증
Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia
차단 캐피털, 레비바 파마슈티컬 주식에 ’매수’ 등급 제시
Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25 - TipRanks.com
Reviva Pharmaceuticals, H.C. Wainwright ’매수’ 등급 재확인